InvestorsHub Logo
Followers 4
Posts 326
Boards Moderated 0
Alias Born 10/19/2005

Re: None

Tuesday, 12/25/2012 12:41:00 PM

Tuesday, December 25, 2012 12:41:00 PM

Post# of 130505
Excellent Dr. Rubinfeld interview:
From 10 yrs ago to give you a sense of what he brings to the table:
http://www.twst.com/interview/8279

Again, I believe he will help AMBS strike an in licensing deal and also get help them get substantial funding. I believe AMBS should be worth at least $75 mill right now (about 4 to 5 times current value). I'm basing this on relative valuation for GDNF with a substantial discount and on patent protection...remember a partner from Hermo Pharma (VC backed and MJFF funded company that challenged the company's MANF patents and lost) was quoted as saying that the company's MANF patents "cause an undue burden" on anyone trying to test MANF or anything with a 90% homology (ie similarity) to it.

http://m.seekingalpha.com/instablog/167303-jonathan-verenger/1348791-exciting-field-in-cure-for-parkinson-s

Don't listen to college kids like solantey with $3000 to their name warning of impending doom because they're naive enough to think they can manipulate a stock. They sold and want back in at lower prices...they see the writing on the wall. They made a mistake. Those of us that have been patient enough to hold and continue to hold will reap massive benefits. It won't be easy to hold with huge gains but the valuation is way too low.